Lineage Cell Therapeutics (LCTX) Gross Margin Growth (5y) (2016 - 2026)
Lineage Cell Therapeutics (LCTX) Gross Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,864.00 |
| Dec 31, 2025 | 3,111.00 |
| Sep 30, 2025 | 1,773.00 |
| Jun 30, 2025 | 1,802.00 |
| Mar 31, 2025 | 1,589.00 |
| Dec 31, 2024 | 454.00 |
| Sep 30, 2024 | 1,910.00 |
| Jun 30, 2024 | 1,061.00 |
| Mar 31, 2024 | 54.00 |
| Dec 31, 2023 | -540.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 22.00 |
| Mar 31, 2023 | 1,056.00 |
| Dec 31, 2022 | -533.00 |
| Sep 30, 2022 | -784.00 |
| Jun 30, 2022 | -472.00 |
| Mar 31, 2022 | -336.00 |
| Dec 31, 2021 | -9,807.00 |
| Sep 30, 2021 | -4,339.00 |
| Jun 30, 2021 | -2,441.00 |